发明名称 Triazole derivative
摘要 A compound represented by the formula (I) below or a pharmaceutically acceptable salt thereof has an effect of inhibiting binding between S1P and its receptor Edg-1(S1P1), and is useful as a pharmaceutical product. [where A represents a sulfur atom, an oxygen atom, a formula —SO— or a formula —SO2—; R1 represents a hydrogen atom, an alkyl group having 1 to 6 carbon atoms or the like; R2 represents an alkyl group having 1 to 6 carbon atoms, a cycloalkyl group having 3 to 8 carbon atoms or the like; R3 represents a hydrogen atom or an alkyl group having 1 to 6 carbon atoms; R4 represents a hydrogen atom, an alkyl group having 1 to 6 carbon atoms, a phenyl group or the like; R5 represents a hydrogen atom or an alkyl group having 1 to 6 carbon atoms; and R6 represents an alkyl group having 1 to 6 carbon atoms, a phenyl group or a substituted phenyl group].
申请公布号 US8022225(B2) 申请公布日期 2011.09.20
申请号 US20050659103 申请日期 2005.08.04
申请人 TAISHO PHARMACEUTICAL CO., LTD 发明人 ONO NAOYA;SATO MASAKAZU;SHIOZAWA FUMIYASU;YAGI MAKOTO;YABUUCHI TETSUYA;TAKAYAMA TETSUO;KATAKAI HIRONORI
分类号 C07D249/12;C07D249/08 主分类号 C07D249/12
代理机构 代理人
主权项
地址
您可能感兴趣的专利